LEU— AI Stock Forecast & Price Targets

Published 7/1/2026 · A free sample of K3vl4r’s AI-powered analysis.

Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.

View the live LEU price forecast →

Centrus Energy is a strategically important domestic HALEU/LEU enricher riding a powerful nuclear-renaissance narrative (Oklo LOI, backlog growth) but trading at ~56x trailing / ~62x forward earnings with deteriorating near-term cash flow (Q1 2026 FCF -$58.3M) and 22% short interest. After a violent round-trip from ~$464 to ~$145 and a bounce to ~$168, the setup is a range-bound consolidation where the story is real but the multiple demands patience. I favor a HOLD with tactical accumulation only on deeper pullbacks — the near-term forecast band skews modestly bullish, but weekly-timeframe reliability is poor and an August earnings print looms as a binary catalyst.

HOLDmedium convictiongenerated 7/1/2026, 7:50:49 AM
Scores
Fundamentals
5.2
Technicals
5.0
Growth potential
8.0
Risk
7.8
Overall
5.9
Charts the model saw
Bear
$130.00
Base
$180.00
Bull
$235.00
over ~6 months
Investment plan
Short term · 1-4 weeks

1-4 week view: HOLD/range-trade. Price is mid-range at $167.87 with weakening momentum (down 8% on the month, -5.4% on the week). I would not chase — buy interest is only warranted on a retest of $150-158 with a tight stop under $144. A break above $185 on volume would flip me to tactical long targeting $205. Do NOT carry a leveraged swing into the August 4 earnings print — that is a binary event with an expected large gap given 22% short interest and 6.25% daily volatility; any short-term target here is PRE-earnings only and earnings is the invalidation. Position sizing should reflect the $13.46 ATR — half normal size or less.

Mid term · 1-6 months

1-6 month view: cautiously constructive but valuation-capped. The Oklo LOI plus a growing backlog and the domestic HALEU policy tailwind should support the story, but 42x forward earnings and negative FCF cap upside until quarterly execution converts narrative into cash. Base case: range trade $150-$220 with an eventual resolution higher if HALEU capacity milestones hit. Expected return range in a base case: flat to +15% over 6 months; bull case +40% on a contract announcement or short squeeze; bear case -20% on a soft earnings print or capex overrun. What would change my mind bullishly: a clean earnings beat + guidance raise, or a firm HALEU offtake contract (not LOI). Bearishly: FCF worsening below -$75M/quarter, or contract slippage.

Long term · 1-3 years

1-3 year view: this is a call option on U.S. nuclear reindustrialization. If Centrus successfully scales HALEU production ahead of the SMR/advanced-reactor wave (2027-2029 deliveries), earnings power could be multiples of today's $2.75 TTM EPS and the current cash hoard is the funding source. The terminal thesis is that a domestic, DOE-aligned enricher with the only U.S. HALEU license becomes strategically indispensable and re-rates on secular volumes, not spot SWU. Biggest structural risks: (1) execution/timeline on Piketon HALEU capacity — nuclear projects historically slip; (2) government-contract dependence and political cycle risk; (3) return of Russian enrichment supply if geopolitics normalize, compressing SWU prices; (4) dilution risk if capex outruns the $1.87B cash pile.

Fundamentals

Revenue is choppy and contract-timing driven: Q2'25 $154.5M → Q3'25 $74.9M → Q4'25 $146.2M → Q1'26 $76.7M, with TTM sales of $452.3M actually down 4% Y/Y. Gross margin swung from 34.9% in Q2'25 to -5.7% in Q3'25 back to 41.1% in Q1'26 — this is a lumpy SWU-delivery business, not a smooth growth story. Operating income in Q1'26 was just $0.8M despite the strong gross print, and TTM operating margin is essentially breakeven (-0.26%). The balance sheet is the standout positive: $1.87B cash / $94.97 per share (roughly 57% of the market cap in cash), $1.18B total debt, current ratio 5.72 — this cash pile likely reflects capital raised for HALEU expansion. However, cash flow has flipped hard negative: operating cash flow -$35.1M and FCF -$58.3M in Q1'26, following -$48.4M/-$58M in Q4'25, as capex ramps ($23.2M in Q1'26 vs $3.6M a year earlier). ROE 12.3% and profit margin 13.4% look decent on TTM but are distorted by one-off gains; forward EPS $3.97 implies 42x forward P/E which is rich for a lumpy, capex-heavy small-cap. Capital allocation is defensible — spending the war chest on capacity for a national-security-priority product — but investors are underwriting execution, not current earnings power.

Technicals

Across timeframes the tape is a broad consolidation after a parabolic blow-off. The 1D chart shows the January spike to ~$340, a crash to ~$145 in April, and a recovery into a $160-$200 range; price at $167.87 sits -31.8% below the 200-SMA and -9.9% below the 50-SMA, with RSI 46.6 — neutral, not oversold. The 1H shows a lower-high pattern from ~$205 down to ~$170, with the forecast band pointing modestly higher toward ~$211, but short-horizon MAPE is ~19% so that target has a wide error bar. The 4H forecast projects a rebound toward ~$241 by early September, which lines up with the top of the multi-month range. The weekly forecast is more bearish/mean-reverting and, critically, weekly directional accuracy (33%) is BELOW the 51% naive baseline — I discount the weekly path heavily. Key levels: support $160 (recent pivot) and $144-150 (52-week low / spring base); resistance $185-190 (50-DMA / prior supply), then $205-210, with $240 as the range top. Structure is a symmetrical consolidation — a break above $190 on volume would confirm trend repair; a loss of $145 would open $120s. 22% short float plus $13.46 ATR mean any catalyst produces outsized moves.

News read

The core positive catalyst is the Oklo HALEU letter-of-intent (multiple articles, June 22-23), which validates Centrus as the go-to domestic HALEU supplier for advanced reactor developers — this is a genuine, backlog-building event, not noise, and analyst commentary framed it as a step toward supply-chain reindustrialization for U.S. nuclear. Coverage since then has been more mixed: a June 30 Motley Fool piece frames the 32% drawdown as a buying opportunity into a new ATH, while StockStory (June 26 and 29) argues to avoid or trim on valuation and growth risk. Two June 23-24 sell-offs were driven by exogenous oil/Iran headlines rather than company-specific news, which is a reminder that LEU trades with commodity/geopolitical risk-on/off flows even though its fundamentals aren't directly tied to crude. Signal: the HALEU-supply thesis is firming and the order book is growing. Noise: day-to-day gyrations tied to Middle East headlines and generic 'discount vs value trap' framing pieces.

Growth / roadmap
  • Oklo HALEU letter-of-intent (June 2026) — first advanced-reactor customer commitment starting 2029, validates Centrus as domestic HALEU supplier of choice
  • Backlog acceleration cited in June 23 coverage as a trigger for stock upside — watch for backlog disclosure at Q2 earnings
  • $1.87B cash / $94.97 per share funds Piketon HALEU expansion without near-term dilution risk
  • Forward EPS $3.97 vs trailing $2.75 implies analyst expectation of ~44% earnings growth as delivery cadence normalizes
  • Analyst target price $272 (Recom 1.71) implies ~62% upside if consensus execution assumptions hold
Risks
  • Rich valuation: 55.6x trailing / 42-62x forward P/E and 5.78x EV/Sales leave no margin for execution slippage
  • Q1 2026 FCF -$58.3M and operating cash flow -$35.1M — cash burn accelerating as capex ramps to $23.2M/quarter
  • Lumpy revenue: Q3'25 gross margin was -5.7% on $74.9M sales — any single soft quarter can rerate the stock sharply
  • 22.3% short float + 4.65 short ratio + $13.46 ATR = extreme two-way volatility, especially into the Aug 4 earnings print
  • 31.8% below 200-SMA and -33.9% half-year performance signal an unbroken downtrend has not yet reversed
  • Weekly forecast model directional accuracy 33% (below 51% naive baseline) — longer-horizon model signals unreliable
  • Geopolitical whipsaw: June sell-offs tied to Iran/oil headlines show the name trades with macro risk-off flows
  • Prior published base-case targets have run ~15% above realized price — I am materially discounting momentum-based upside

Get AI analysis on any stock

This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord